Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Peter Merkel

Professor

University of Pennsylvania

United States

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacotherapy

30%

Internal Medicine

30%

Therapeutic Apheresis

20%

Autoinflammatory Disease

20%

Pharmacoepidemiology

10%

Patient Recruitment

10%

Neuromarketing

10%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles8

The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial

Article Link

Year:

2023

Direct-to-Consumer Recruitment Methods via Traditional and Social Media to Aid in Research Accrual for Clinical Trials for Rare Diseases: Comparative Analysis Study

Article Link

Year:

2023

Development and Validation of a Simulation Model for Treatment to Maintain Remission in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

Article Link

Year:

2023

Response to: Correspondence on ‘2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis’ by Joanna C Robsonet aland ‘2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis’ by Pimentel-Quirozet al

Article Link

Year:

2023

Patient and Physician Global Assessments of Disease Status in Systemic Sclerosis

Article Link

Year:

2023

Engaging Multistakeholder Perspectives to Identify Patient‐Centered Research Priorities Regarding Vaccine Uptake Among Adults With Autoimmune Conditions

Article Link

Year:

2023

Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCT

Article Link

Year:

2022

Web-Based Mindfulness-Based Interventions for Well-being: Randomized Comparative Effectiveness Trial

Article Link

Year:

2022

Collaborators12

Michael Walsh

Associate Professor

McMaster University

CANADA

Mark J. Pletcher

UNITED STATES

Marc Rothenberg

Professor and Director of Allergy/Immunology

Cincinnati Children's Hospital Medical Center

UNITED STATES

Yuqing Zhang

Professor of Medicine in Residence

Massachusetts General Hospital

UNITED STATES

David Jayne

Professor

University of Cambridge

UNITED KINGDOM

Ashira Blazer

Assistant Professor

Hospital for Special Surgery

UNITED STATES

vibeke strand

Adjunct Clinical Professor

Stanford University School of Medicine

UNITED STATES

Shubhasree Banerjee

University of Pennsylvania

UNITED STATES

Nader Khalidi

McMaster University

CANADA

Mitchell R. Lunn

Stanford University School of Medicine

UNITED STATES

MUSTAFA SAHIN

Professor

Boston Children's Hospital

UNITED STATES

Richard Watts

University of Oxford

UNITED KINGDOM

How do I reach out?

Meet Kite AI